1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc XNAS: SPRY
10.21 -0.36 (-3.41%)
1.5M
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

ARS Pharma Inc - SPRY - stock price prediction, stock price target, analyst ratings from 6 analysts

ARS Pharma Inc has a share price target of US$ 28, revenue growth forecast of -8.0%, and profit growth estimate of -2268.9% for FY25, based on top 6 analyst calls.